APA (7th ed.) Citation

Mai Maher, Asmaa E. Kassab, Ashraf F. Zaher, & Zeinab Mahmoud. (2019). Novel pyrazolo[3,4-d]pyrimidines: Design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Mai Maher, Asmaa E. Kassab, Ashraf F. Zaher, and Zeinab Mahmoud. Novel Pyrazolo[3,4-d]pyrimidines: Design, Synthesis, Anticancer Activity, Dual EGFR/ErbB2 Receptor Tyrosine Kinases Inhibitory Activity, Effects on Cell Cycle Profile and Caspase-3-mediated Apoptosis. Taylor & Francis Group, 2019.

MLA (9th ed.) Citation

Mai Maher, et al. Novel Pyrazolo[3,4-d]pyrimidines: Design, Synthesis, Anticancer Activity, Dual EGFR/ErbB2 Receptor Tyrosine Kinases Inhibitory Activity, Effects on Cell Cycle Profile and Caspase-3-mediated Apoptosis. Taylor & Francis Group, 2019.